Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $5.00 billion. The enterprise value is $4.10 billion.

Market Cap	5.00B
Enterprise Value	4.10B

Important Dates

The last earnings date was Monday, March 2, 2026, before market open.

Earnings Date	Mar 2, 2026
Ex-Dividend Date	n/a

Share Statistics

APGE has 69.49 million shares outstanding. The number of shares has increased by 9.96% in one year.

Current Share Class	55.36M
Shares Outstanding	69.49M
Shares Change (YoY)	+9.96%
Shares Change (QoQ)	+14.61%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	92.04%
Float	51.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.44
P/TBV Ratio	5.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 26.57, with a Debt / Equity ratio of 0.01.

Current Ratio	26.57
Quick Ratio	26.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31.57% and return on invested capital (ROIC) is -21.75%.

Return on Equity (ROE)	-31.57%
Return on Assets (ROA)	-21.11%
Return on Invested Capital (ROIC)	-21.75%
Return on Capital Employed (ROCE)	-31.41%
Weighted Average Cost of Capital (WACC)	11.92%
Revenue Per Employee	n/a
Profits Per Employee	-$980,241
Employee Count	261
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, APGE has paid $278,000 in taxes.

Income Tax	278,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.61% in the last 52 weeks. The beta is 1.40, so APGE's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	+86.61%
50-Day Moving Average	72.27
200-Day Moving Average	54.74
Relative Strength Index (RSI)	51.16
Average Volume (20 Days)	806,540

Short Selling Information

The latest short interest is 8.62 million, so 12.40% of the outstanding shares have been sold short.

Short Interest	8.62M
Short Previous Month	8.70M
Short % of Shares Out	12.40%
Short % of Float	16.63%
Short Ratio (days to cover)	9.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-285.60M
Pretax Income	-255.57M
Net Income	-255.84M
EBITDA	-284.18M
EBIT	-285.60M
Earnings Per Share (EPS)	-$4.22

Balance Sheet

The company has $730.19 million in cash and $8.85 million in debt, with a net cash position of $894.07 million or $12.87 per share.

Cash & Cash Equivalents	730.19M
Total Debt	8.85M
Net Cash	894.07M
Net Cash Per Share	$12.87
Equity (Book Value)	903.88M
Book Value Per Share	13.21
Working Capital	713.45M

Cash Flow

In the last 12 months, operating cash flow was -$227.45 million and capital expenditures -$5.15 million, giving a free cash flow of -$232.60 million.

Operating Cash Flow	-227.45M
Capital Expenditures	-5.15M
Free Cash Flow	-232.60M
FCF Per Share	-$3.35

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.96%
Shareholder Yield	n/a
Earnings Yield	-5.12%
FCF Yield	-4.66%

Analyst Forecast

The average price target for APGE is $103.22, which is 42.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$103.22
Price Target Difference	42.42%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-10.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2